Skip to main
A

Agilent Technologies (A) Stock Forecast & Price Target

Agilent Technologies (A) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 47%
Buy 47%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Agilent Technologies is a leading life science and diagnostic firm with diverse operations and a geographically diverse revenue base. The company has a strong presence in key end markets, such as biopharmaceuticals and advanced materials, and has demonstrated strong revenue growth. Its focus on product cycles, reshoring and capex investments in various industries sets it apart from its peers. Despite some potential challenges in cyclical markets and exposure to China, Agilent's strong management team and commitment to sustainability make it a favorable investment with solid long-term growth potential.

Bears say

Agilent Technologies is facing significant headwinds that could affect its margin expansion and sustainability efforts, including tariffs, sales phasing, and weather-related challenges. Additionally, the company's significant exposure to China, where markets are currently mixed, could further impact its growth potential. There are also potential risks to its stock performance, such as macroeconomic deterioration and value-destructive M&A.

Agilent Technologies (A) has been analyzed by 15 analysts, with a consensus rating of Buy. 47% of analysts recommend a Strong Buy, 47% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Agilent Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Agilent Technologies (A) Forecast

Analysts have given Agilent Technologies (A) a Buy based on their latest research and market trends.

According to 15 analysts, Agilent Technologies (A) has a Buy consensus rating as of Jun 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $160.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $160.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Agilent Technologies (A)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.